Date: 2012-04-06
Type of information:
Product name: lisuride hydrogenmaleate
Compound: lisuride hydrogenmaleate
Therapeutic area:
Action mechanism: Lisuride is a dopamine and serotonin receptor partial agonist.
Company: Sinoxa Pharma (Germany)
Disease: pulmonary arterial hypertension (PAH)
chronic thromboembolic pulmonary hypertension
Latest news:
Patents:
Submission of marketing authorization application USA :
Submission of marketing authorization application UE:
Withdrawal of marketing authorization application USA:
Withdrawal of marketing authorization application UE:
US authorization:
UE authorization:
Favourable opinion UE:
Favourable opinion USA:
Orphan status USA:
Orphan status UE: 2011-05-13
Pediatric exclusivit _USA:
Pediatric exclusivity UE: OTC status: Other news:
